Tag

Lenacapavir

All articles tagged with #lenacapavir

business2 days ago•13 min saved

Gilead's Lenacapavir Dilemma: A HIV Breakthrough Hindered by Access Rules

Lenacapavir could be a game-changer in HIV, but Gilead’s practice of not selling directly to Doctors Without Borders (MSF), limiting supply via the Global Fund to just 2 million doses over three years, and its licensing that excludes 26 middle-income countries has sparked criticism that profits trump public health. Gilead argues it is expanding access through generic licenses and deals with Global Fund and PEPFAR to deliver low- or no-profit supply, with a broader rollout planned in 2027 via generics in 120 countries, but concrete expansion remains uncertain.

via Los Angeles Times|

#access-to-medicines #business #gilead

health11 days ago•2 min saved

Gilead urged to sell long-acting HIV prevention drug directly to MSF

Doctors Without Borders (MSF) is pressing Gilead to directly sell lenacapavir, a two-a-year injectable PrEP for HIV prevention, to MSF for use in its humanitarian programs. Gilead has refused, directing MSF to obtain doses through the Global Fund, which has a limited supply, leaving many vulnerable people without access. MSF cites humanitarian need and calls for an urgent meeting by April 13 to decide pricing and delivery timelines.

via Doctors Without Borders|

#gilead #health #hivaids

world17 days ago•18 min saved

Lenacapavir arrives in Eswatini as AIDS battle hinges on rollout

A new HIV prevention drug, lenacapavir, delivered as a twice-yearly injection, is being rolled out in Eswatini and nine high‑risk countries in a bid to end AIDS, described by UN officials as the closest thing to a vaccine. While it could dramatically reduce new infections if scaled globally, the rollout is hampered by years of foreign aid cuts that shuttered mobile clinics and constrained supply. The UN and Global Fund aim to reach millions, but plans to reach about two million people by 2028 fall well short of needs, underscoring the need for expanded funding and procurement to avoid repeating past delays that cost lives.

via The Independent|

#aids #eswatini #hiv

health1 month ago•4 min saved

Zimbabwe rolls out lenacapavir HIV prevention, a new adherence-friendly approach

Zimbabwe launched a national lenacapavir program, a twice-yearly injectable HIV prevention treatment that could replace daily PrEP pills. Funded by the U.S. government and the Global Fund, the initial rollout covers about 46,000 high-risk individuals across 24 sites, with priority for adolescent girls, young women and sex workers, as part of the country’s broader effort to curb HIV.

via africanews.com|

#global-fund #health #hiv

health4 months ago•1 min saved

Africa to Launch Groundbreaking HIV Prevention Shots

South Africa, Eswatini, and Zambia have begun using a groundbreaking HIV prevention injection, lenacapavir, which reduces transmission risk by over 99.9% and is administered twice a year, marking a significant advancement in HIV prevention efforts in Africa, though access and cost remain challenges.

via Barron's|

#africa #health #hiv-prevention

health5 months ago•4 min saved

Zimbabwe's HIV Shot Sparks Debate Amid Regional Prevention Efforts

Zimbabwe is set to be among the first countries to roll out lenacapavir, a groundbreaking twice-yearly HIV prophylactic, which has shown over 99% efficacy in trials and is hailed as a potential 'miracle drug' in HIV prevention, though concerns about cost and accessibility remain.

via DW|

#aids-prevention #health #hiv

health5 months ago•3 min saved

South Africa's Health Minister Praises New HIV Prevention Jab Amid Supply Concerns

South Africa's health minister announced the introduction of lenacapavir, the world's first twice-yearly HIV prevention injection, with an initial limited supply of nearly half a million doses starting in April 2026, amid concerns over funding cuts and licensing issues affecting local manufacturing and access.

via ABC News - Breaking News, Latest News and Videos|

#global-health #health #hiv-prevention

health5 months ago•9 min saved

Breaking Barriers to End HIV

A new drug called lenacapavir, approved for HIV prevention, offers a twice-yearly injection with near-vaccine efficacy, potentially transforming HIV prevention efforts worldwide, especially in low-income countries, but its impact will depend heavily on political and logistical factors.

via vox.com|

#global-health #health #hiv

health6 months ago•5 min saved

Global Effort Launches Affordable HIV Prevention to End Epidemic

Jamaica is considering a pilot program for the FDA-approved injectable HIV drug lenacapavir, which could significantly improve adherence and prevention efforts, especially among young people, with plans for free access in the public health system and potential scaling up based on pilot outcomes.

via Jamaica Observer|

#health #hiv #hiv-prevention

health6 months ago•3 min saved

Affordable HIV Prevention: Lenacapavir to Cost $40 Annually in LMICs

A new twice-yearly HIV prevention injection, lenacapavir, is set to be more affordable and accessible in resource-limited countries like Nigeria, sparking mixed reactions due to skepticism and conspiracy theories, despite potential benefits in reducing HIV transmission and improving adherence.

via Punch Newspapers|

#health #hiv-prevention #injectable-prep

health6 months ago•3 min saved

Global Partnerships Boost Access to Affordable HIV Prevention Treatments

A new HIV prevention drug, Lenacapavir, will be made available at a drastically reduced cost of $40 in over 100 low- and middle-income countries by 2027, potentially transforming HIV prevention efforts worldwide and helping to curb the epidemic.

via BBC|

#affordable-access #aids-prevention #global-health

health6 months ago•4 min saved

Global Partnership Launches Affordable HIV Prevention to End Epidemic

Cheap supplies of the groundbreaking HIV prevention injection lenacapavir will be available in many poorer countries from 2027 at $40 per patient per year, potentially transforming efforts to end the global HIV epidemic, with support from major health organizations and generic drug manufacturers.

via The Guardian|

#affordable-medicine #global-health #health

health6 months ago•31 min saved

CDC Endorses Injectable Lenacapavir for HIV Prevention in 2025

The CDC strongly recommends the use of injectable lenacapavir, administered every 6 months, as an effective and safe option for HIV preexposure prophylaxis in persons weighing at least 35 kg, based on high-certainty evidence from clinical trials showing near 100% efficacy in preventing HIV infection.

via Centers for Disease Control and Prevention | CDC (.gov)|

#cdc-guidelines #health #hiv-prevention

health7 months ago•7 min saved

Gilead's New HIV Drug Gains U.S. Support and FDA Approval

The U.S. announced support for lenacapavir, a groundbreaking HIV prevention drug requiring only biannual injections, aiming to reach 2 million people by 2028 and significantly impact the global HIV epidemic, especially in low- and middle-income countries.

via NPR|

#breakthrough-drug #global-health #health

health7 months ago•2 min saved

PEPFAR and Gilead Collaborate to Expand HIV Prevention with Breakthrough Drug

The U.S. Department of State announced a PEPFAR initiative to bring Gilead Sciences' breakthrough HIV drug lenacapavir to high-burden countries, aiming to reach up to 2 million people by 2028. The twice-yearly injectable medication, which has shown over 99% effectiveness in clinical trials, will be distributed with the support of the U.S. government and the Global Fund, at no profit from Gilead, to help prevent mother-to-child transmission and reduce HIV infections globally.

via U.S. Department of State (.gov)|

#gilead-sciences #global-health #health